Scientists ’on brink of cure’ for superbug
The Independent, May 22, 2008
Scientists have developed a drug that they say could be cure for MRSA. A British research firm claims that their discovery represented a "major breakthrough" in the battle against MRSA, a superbug responsible for the deaths of more than 1,600 patients in the UK every year. The firm, Destiny Pharma, is already carrying out human trials on the drug, and hopes to make the drug available in hospitals within three years.
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- CA Powers Up $80M HIE to 'Create Value in the Data'
- TJC Warns Hospitals of Deadly Medical Tubing Mistakes
- 3 Traits Personality Assessments Can't Reveal
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Consumerism Drives Healthcare Branding, Rebranding Efforts